Literature DB >> 1917974

Localization of the human complement component C3 binding site on the IgG heavy chain.

J M Shohet1, L Bergamaschini, A E Davis, M C Carroll.   

Abstract

The location of the covalent binding site of the third component of complement (C3) on the IgG heavy chain was determined by sequence analysis of peptides generated by cyanogen bromide digestion of C3-IgG adducts. Activation of the alternative pathway by incubation of heat-aggregated human IgG1 with fresh normal human plasma formed covalent adducts of C3b-IgG. CNBr peptides of these adducts were transferred to a polyvinylidene difluoride membrane, and amino-terminal sequences were determined. A 40-kDa dipeptide containing the covalent bond was identified by labeling the free thiol group (generated during activation of the internal thioester of C3b) with iodo[1-14C]acetamide and analyzed by amino acid sequencing. The resulting double sequence suggested an adduct with NH2 termini at residue 938 (pro-C3 numbering) of C3 (75 residues NH2-terminal to the thioester) and residue 84 in the variable region of the IgG heavy chain. These results combined with results from hydroxylamine treatment (splits ester linkage between C3b and IgG) imply that this adduct peptide consists of a 22-kDa C3 fragment and an 18-kDa IgG fragment. Therefore, C3 binds covalently within the region extending from the last 20 residues of the variable region through the first 20 residues of CH2.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1917974

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification.

Authors:  E Jelezarova; A Vogt; H U Lutz
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

2.  Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes.

Authors:  W Zhang; P J Lachmann
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

3.  Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.

Authors:  M B Marques; D L Kasper; M K Pangburn; M R Wessels
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

4.  Inhibition of IgM antibody-mediated aggregation of Trypanosoma gambiense in the presence of complement.

Authors:  T Takayanagi; H Kawaguchi; Y Yabu; M Itoh; K Yano
Journal:  Experientia       Date:  1992-10-15

Review 5.  Immunoglobulin in the control of complement action.

Authors:  M M Frank; V D Miletic; H Jiang
Journal:  Immunol Res       Date:  2000       Impact factor: 4.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.